BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes
Since its inception, the company has either acquired or taken a majority stake in five companies
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The platform will provide a safe and nurturing space for women, and non-binary individuals
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
Early-stage research suggests the potential to prevent and treat all dengue serotypes and builds on Johnson & Johnson's work to advance science against emerging and entrenched global public health threats
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The transaction is anticipated to close in the first quarter of 2022
Subscribe To Our Newsletter & Stay Updated
